Literature DB >> 28371441

Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study.

Huah Shin Ng1, David Roder2, Bogda Koczwara3, Agnes Vitry1.   

Abstract

AIM: To assess the prevalence of comorbidities and measures of physical and mental health among the cancer patients and survivors compared with the general population.
METHODS: Data collected by the Australian Bureau of Statistics from 2011-2012 National Health Survey were utilized for this cross-sectional study. Comparisons were made between adults aged 25 years and over with history of cancer (n = 2170) and those respondents who did not report having had a cancer (n = 11 592) using logistic regression models. Analyses were repeated according to cancer status (current cancer vs. cancer survivor).
RESULTS: People with history of cancer had significantly higher odds of reporting mental and behavioral problems (overall cancer group adjusted odds ratio 1.36, 95 percent confidence interval 1.20-1.54; current cancer 2.53, 1.97-3.27; cancer survivor 1.20, 1.05-1.38), circulatory conditions (overall cancer group 1.25, 1.12-1.39; current cancer 1.38, 1.08-1.76; cancer survivor 1.22, 1.09-1.38), musculoskeletal conditions (overall cancer group 1.37, 1.24-1.52; current cancer 1.66, 1.30-2.12; cancer survivor 1.33, 1.19-1.48) and endocrine system disorders (overall cancer group 1.19, 1.06-1.34; current cancer 1.29, 1.00-1.66; cancer survivor 1.17, 1.04-1.33) compared with the noncancer group. Cancer patients and survivors were more likely to report poor health status, a higher level of distress, and a greater number of chronic conditions compared with the noncancer group.
CONCLUSION: Poor health and comorbidity is more prevalent among cancer patients and survivors than the noncancer population. Our results further support the need to develop models of care that effectively address multiple chronic conditions experienced by the cancer population.
© 2017 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Australia; cancer; comorbidity; measures of health; prevalence

Mesh:

Year:  2017        PMID: 28371441     DOI: 10.1111/ajco.12677

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  23 in total

1.  Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.

Authors:  Melanie R Keats; Yunsong Cui; Vanessa DeClercq; Scott A Grandy; Ellen Sweeney; Trevor J B Dummer
Journal:  Support Care Cancer       Date:  2020-05-22       Impact factor: 3.603

2.  Long-term Somatic Disease Risk in Adult Danish Cancer Survivors.

Authors:  Trille Kristina Kjaer; Elisabeth Anne Wreford Andersen; Jeanette Falck Winther; Pernille Envold Bidstrup; Michael Borre; Henrik Møller; Signe Benzon Larsen; Christoffer Johansen; Susanne Oksbjerg Dalton
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777

3.  The associations of comorbidities and consumption of fruit and vegetable with quality of life among stomach cancer survivors.

Authors:  Ji-Wei Wang; Cheng-Gang Zhang; Qing-Long Deng; Wan-Li Chen; Xian Wang; Jin-Ming Yu
Journal:  Health Qual Life Outcomes       Date:  2018-04-12       Impact factor: 3.186

4.  Are Leading Risk Factors for Cancer and Mental Disorders Multimorbidity Shared by These Two Individual Conditions in Community-Dwelling Middle-Aged Adults?

Authors:  Xianwen Shang; Allison M Hodge; Wei Peng; Mingguang He; Lei Zhang
Journal:  Cancers (Basel)       Date:  2020-06-26       Impact factor: 6.639

5.  Temporal order of cancers and mental disorders in an adult population.

Authors:  David Cawthorpe; Marc Kerba; Aru Narendran; Harleen Ghuttora; Gabrielle Chartier; Norman Sartorius
Journal:  BJPsych Open       Date:  2018-04-19

6.  Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer.

Authors:  Grace Joshy; Joanne Thandrayen; Bogda Koczwara; Phyllis Butow; Rebekah Laidsaar-Powell; Nicole Rankin; Karen Canfell; John Stubbs; Paul Grogan; Louise Bailey; Amelia Yazidjoglou; Emily Banks
Journal:  BMC Med       Date:  2020-12-01       Impact factor: 8.775

7.  An Assessment of Distress Levels of Patients Undergoing Lung Cancer Treatment and Surveillance During the COVID-19 Pandemic.

Authors:  Denise Albano; Melissa Feraca; Barbara Nemesure
Journal:  J Nurse Pract       Date:  2020-11-21       Impact factor: 0.767

8.  Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic.

Authors:  Yuanyuan Wang; Zhizhou Duan; Zikun Ma; Yize Mao; Xiyuan Li; Amanda Wilson; Huiying Qin; Jianjun Ou; Ke Peng; Fangjian Zhou; Chaofeng Li; Zhuowei Liu; Runsen Chen
Journal:  Transl Psychiatry       Date:  2020-07-31       Impact factor: 6.222

9.  Incidence, Progression, and Patterns of Multimorbidity in Community-Dwelling Middle-Aged Men and Women.

Authors:  Xianwen Shang; Wei Peng; Edward Hill; Cassandra Szoeke; Mingguang He; Lei Zhang
Journal:  Front Public Health       Date:  2020-08-18

10.  Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in breast cancer post-treatment follow-up: a study protocol for a phase II randomised controlled trial (the EMINENT trial).

Authors:  Raymond Javan Chan; Jon Emery; Katharine Cuff; Laisa Teleni; Camilla Simonsen; Jane Turner; Monika Janda; Daniel Mckavanagh; Lee Jones; Emma McKinnell; Melissa Gosper; Juanita Ryan; Ria Joseph; Bethany Crowe; Jennifer Harvey; Marissa Ryan; Christine Carrington; Rebecca Nund; Megan Crichton; Steven McPhail
Journal:  Trials       Date:  2020-10-15       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.